The negative outlook reflects the hospital’s significant inpatient volume decline in fiscal year 2018 and history of volume declines, which have constrained revenue growth.
S&P affirmed its “BB+” long-term rating for the hospital.
More articles on healthcare finance:
Shifting to value-based approach best way to reduce health costs, says AMGA
For-profit hospital stock report: Week of Feb. 25-March 1
California health data company’s 138% stock jump a mystery to traders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
